Literature DB >> 18434930

Prognostic model for predicting hearing recovery in idiopathic sudden sensorineural hearing loss.

Ljiljana Cvorović1, Dragoslava Deric, Rudolf Probst, Stefan Hegemann.   

Abstract

HYPOTHESIS: To aid in realistic counseling of patients at the time of their first visit concerning their chances for recovery, we created a simple prognostic model for predicting hearing recovery in idiopathic sudden sensorineural hearing loss (ISSHL).
BACKGROUND: An important element of research on ISSHL is to identify prognostic factors for this disease. Many studies have described predictive indicators to identify patients with a good prognosis needing no or minimal treatment. Only a few of these studies have included a model for calculating the probability for patient recovery, which may be important for clinical work, but these prognostic tables have not achieved widespread use clinically.
METHODS: Evaluation of an electronic patient data base of 541 patients with ISSHL. The standard treatment was carbogen inhalation (95% O2 and 5% CO2 8 times per day in duration of 30 min) and prednisone orally (100 mg in 1 morning dose) for 7 days. Factors that were analyzed included the patient's age, the interval between the onset of symptoms and beginning of treatment, the presence or absence of vertigo and tinnitus, audiometric patterns, the severity of hearing loss, and hearing in the opposite ear. Hearing gain was expressed either as absolute hearing gain or as relative hearing gain. Significant recovery of hearing was defined as the final pure-tone audiometry of 30 dB or less (or the same as the pure-tone audiometry of the opposite ear).
RESULTS: The absolute hearing gain was 15.1 dB. The mean relative hearing gain was 47%. Three hundred one (57%) patients had significant recovery of hearing, and 228 (43%) did not have significant recovery of hearing. Using step-wise multiple linear regression analysis, the most important factors for prognosis included severity of hearing loss, presence of vertigo, time between onset and treatment, the hearing of the other ear, and the audiogram shape (beta coefficient was -0.216, -0.231, 0.211, 0.113, and -0.064, respectively; constant, 0.968). A recovery expectancy table was developed using the data from this study.
CONCLUSION: Based on a retrospective analysis, prognostic indicators for hearing recovery in ISSHL were found to be severity of hearing loss, presence of vertigo, time between onset and treatment, the hearing of the other ear, and the audiogram shape. We created a model for calculating the probability for hearing recovery based on the analysis of 529 patients with unilateral ISSHL.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18434930     DOI: 10.1097/MAO.0b013e31816fdcb4

Source DB:  PubMed          Journal:  Otol Neurotol        ISSN: 1531-7129            Impact factor:   2.311


  43 in total

1.  Early combination treatment with intratympanic steroid injection in severe to profound sudden sensorineural hearing loss improves speech discrimination performance.

Authors:  Young Ho Kim; Kyung Tae Park; Byung Yoon Choi; Min Hyun Park; Jun Ho Lee; Seung-Ha Oh; Sun O Chang
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-12-08       Impact factor: 2.503

2.  Analysis of hearing improvement in patients with severe to profound sudden sensorineural hearing loss according to the level of pure tone hearing threshold.

Authors:  Seok Min Hong; Young Gil Ko; Chan Hum Park; Jun Ho Lee; Ji Heui Kim
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-12-06       Impact factor: 2.503

3.  Prediction model for hearing outcome in patients with idiopathic sudden sensorineural hearing loss.

Authors:  Hideaki Suzuki; Takanori Mori; Koichi Hashida; Minori Shibata; Khac-Hung Nguyen; Tetsuro Wakasugi; Nobusuke Hohchi
Journal:  Eur Arch Otorhinolaryngol       Date:  2010-11-03       Impact factor: 2.503

4.  Hearing Changes After Intratympanically Applied Steroids for Primary Therapy of Sudden Hearing Loss: A Meta-analysis Using Mathematical Simulations of Drug Delivery Protocols.

Authors:  Arne Liebau; Olivia Pogorzelski; Alec N Salt; Stefan K Plontke
Journal:  Otol Neurotol       Date:  2017-01       Impact factor: 2.311

5.  Analysis of 101 patients with severe to profound sudden unilateral hearing loss treated with explorative tympanotomy and sealing of the round window membrane.

Authors:  Daniel Kampfner; Andreas Anagiotos; Jan Christoffer Luers; Karl-Bernd Hüttenbrink; Simon F Preuss
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-09-22       Impact factor: 2.503

6.  Systemic, intratympanic and combined administration of steroids for sudden hearing loss. A prospective randomized multicenter trial.

Authors:  Michael Tsounis; George Psillas; Miltiadis Tsalighopoulos; Victor Vital; Nicolas Maroudias; Konstantinos Markou
Journal:  Eur Arch Otorhinolaryngol       Date:  2017-11-22       Impact factor: 2.503

7.  Early hearing improvement predicts the prognosis of idiopathic sudden sensorineural hearing loss.

Authors:  Marie N Shimanuki; Seiichi Shinden; Naoki Oishi; Noriomi Suzuki; Kaho Iwabu; Tsubasa Kitama; Amina Kida; Koji Sakamoto; Kaoru Ogawa
Journal:  Eur Arch Otorhinolaryngol       Date:  2021-01-02       Impact factor: 2.503

8.  Is it Beneficial to Treat Patients Presenting Three Weeks or Longer after the Onset of Sudden Sensorineural Hearing Loss?

Authors:  Itay Chen; Ohad Cohen; Chanan Shaul; Jean-Yves Sichel; Ronen Perez
Journal:  J Int Adv Otol       Date:  2020-12       Impact factor: 1.017

9.  Feasibility of three-dimensional fluid-attenuated inversion recovery magnetic resonance imaging as a prognostic factor in patients with sudden hearing loss.

Authors:  Ho Yun Lee; Su Young Jung; Moon Suh Park; Seung Geun Yeo; So Yoon Lee; Sun Kyu Lee
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-11-15       Impact factor: 2.503

10.  Use of intratympanic dexamethasone for the therapy of low frequency hearing loss.

Authors:  Necat Alatas
Journal:  Eur Arch Otorhinolaryngol       Date:  2008-12-20       Impact factor: 2.503

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.